Suppr超能文献

血红素(血色素)聚合及其被喹啉类抗疟药抑制的情况。

Haematin (haem) polymerization and its inhibition by quinoline antimalarials.

作者信息

Ridley R G, Dorn A, Vippagunta S R, Vennerstrom J L

机构信息

Pharmaceuticals Division (PRPI), F. Hoffmann-La Roche, Basel, Switzerland.

出版信息

Ann Trop Med Parasitol. 1997 Jul;91(5):559-66. doi: 10.1080/00034989760932.

Abstract

Haematin (ferriprotoporphyrin IX) is released from haemoglobin during its degradation in the malarial parasites' food vacuole and is detoxified by its polymerization into a form of beta-haematin called haemozoin, or malarial pigment. This process is protein independent in vitro. Quinoline antimalarial blood schizonticides accumulate in the food vacuole and may inhibit haematin polymerization by binding to haematin and preventing its incorporation into the growing haemozoin chain. Drug resistance to quinolines is thought to be due to reduced accumulation of the drug in the food vacuole. As some quinolines overcome this resistance, quinolines, as a class, remain a potential source of future antimalarial drugs.

摘要

血红素(高铁原卟啉IX)在疟原虫食物泡内血红蛋白降解过程中释放出来,并通过聚合成一种称为疟色素或疟原虫色素的β-血红素形式而解毒。该过程在体外不依赖蛋白质。喹啉类抗疟血内裂殖体杀灭剂在食物泡中蓄积,并可能通过与血红素结合并阻止其掺入生长中的疟色素链来抑制血红素聚合。对喹啉类药物的耐药性被认为是由于药物在食物泡中的蓄积减少。由于一些喹啉类药物可克服这种耐药性,因此喹啉类药物作为一个类别,仍然是未来抗疟药物的潜在来源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验